Buscar
01/01/2023
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion
Caballero A.C., Escribà-Garcia L., Pujol-Fernández P., Escudero-López E., Ujaldón-Miró C., Montserrat-Torres R., Sierra J., Alvarez-Fernández C., Briones J.. High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion. CANCER GENE THERAPY. 2023; 30(1)DOI:10.1038/s41417-022-00518-6. PMID:36031661. IF:4.800(Q1/2D).
01/01/2023
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope
Del Principe, MI, Seidel, D, Criscuolo, M, Dargenio, M, Racil, Z, Piedimonte, M, Marchesi, F, Nadali, G, Koehler, P, Fracchiolla, N, Cattaneo, C, Klimko, N, Spolzino, A, Karapinar, DY, Demiraslan, H, Duarte, RF, Demeter, J, Stanzani, M, Melillo, LMA, Basilico, CM, Cesaro, S, Paterno, G, Califano, C, Delia, M, Buzzatti, E, Busca, A, Cornely, OA, Pagano, L, Alakel, N, Arsenijevi'c, VA, Camus, V, Falces-Romero, I, Itzhak, L, Kouba, M, Martino, R, Sedlacek, P, Weinbergerova, B. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope. MYCOSES. 2023; 66(1)DOI:10.1111/myc.13524. PMID:36064299. IF:4.100(Q1/2D).
01/01/2023
Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols
Barba, P, Morgades, M, Montesinos, P, Gonzalez-Campos, J, Torrent, A, Gil, C, Bernal, T, Tormo, M, Mercadal, S, Novoa, S, Garcia-Cadenas, I, de Llano, MPQ, Cervera, M, Coll, R, Bermudez, A, Amigo, ML, Monsalvo, S, Esteve, J, Garcia-Boyero, R, Novo, A, Rivas, JMH, Cladera, A, Martinez-Sanchez, P, Serrano, J, Artola, MT, Soria, B, Abella, E, Vall-Llovera, F, Bergua, J, Herrera, P, Barrios, D, Ribera, JM. Impact of Center-related Characteristics and Macroeconomic Factors on the Outcome of Adult Patients With Acute Lymphoblastic Leukemia Treated With Pediatric-inspired Protocols. Hemasphere. 2023; 7(1)DOI:10.1097/HS9.0000000000000810. PMID:36583094. IF:11.900(Q1/1D).
01/01/2023
High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion (vol 30, pg 51, 2023)
Caballero A.C., Escribà-Garcia L., Pujol-Fernández P., Escudero-López E., Ujaldón-Miró C., Montserrat-Torres R., Sierra J., Alvarez-Fernández C., Briones J.. High CAR intensity of expression confers enhanced antitumor effect against lymphoma without functional exhaustion (vol 30, pg 51, 2023). CANCER GENE THERAPY. 2023; 30(1)DOI:10.1038/s41417-022-00564-0. PMID:36460806. IF:4.800(Q1/2D).
01/01/2023
LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors
Cruz D., Rodríguez-Romanos R., González-Bartulos M., García-Cadenas I., de la Cámara R., Heras I., Buño I., Santos N., Lloveras N., Velarde P., Tuset E., Martínez C., González M., Sanz G.F., Ferrá C., Sampol A., Coll R., Pérez-Simón J.A., López-Jiménez J., Jurado M., Gallardo D.. LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1066393. PMID:36742309. IF:5.700(Q1/3D).
01/01/2023
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
Kwon M., Iacoboni G., Reguera J.L., López Corral L., Morales R.H., Ortiz-Maldonado V., Guerreiro M., Caballero A.C., Domínguez M.L.G., Pina J.M.S., Mussetti A., Sancho J.M., Bastos-Oreiro M., Catala E., Delgado J., Henriquez H.L., Sanz J., Calbacho M., Bailén R., Carpio C., Ribera J.M., Sureda A., Briones J., Hernandez-Boluda J.C., Cebrián N.M., Martin J.L.D., Martín A., Barba P.. Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma. HAEMATOLOGICA. 2023; 108(1)DOI:10.3324/haematol.2022.280805. PMID:35770532. IF:10.100(Q1/2D).
01/01/2023
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development
Dickinson M.J., Barba P., Jäger U., Shah N.N., Blaise D., Briones J., Shune L., Boissel N., Bondanza A., Mariconti L., Marchal A.-L., Quinn D.S., Yang J., Price A., Sohoni A., Treanor L.M., Orlando E.J., Mataraza J., Davis J., Lu D., Zhu X., Engels B., Moutouh-de Parseval L., Brogdon J.L., Moschetta M., Flinn I.W.. A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development. Cancer Discovery. 2023; 13(9)DOI:10.1158/2159-8290.CD-22-1276. PMID:37249512. IF:30.600(Q1/1D).
01/01/2023
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: A survey-based study
Solano C., Castro-Rebollo P., Pérez-Martínez A., López-Corral L., Barba-Suñol P., Kwon M., Ortiz V., Sanz-Caballer J., Caballero A.C., Martínez J., Cedillo Á., Sureda A.. Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: A survey-based study. BMJ Open. 2023; 13(7)DOI:10.1136/bmjopen-2022-071371. PMID:37491085. IF:2.400(Q1/3D).
01/01/2023
A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts
Muñoz A., Ay C., Grilz E., López S., Font C., Pachón V., Castellón V., Martínez-Marín V., Salgado M., Martínez E., Calzas J., Ortega L., Rupérez A., Salas E., Pabinger I., Soria J.M.. A Clinical-Genetic Risk Score for Predicting Cancer-Associated Venous Thromboembolism: A Development and Validation Study Involving Two Independent Prospective Cohorts. JOURNAL OF CLINICAL ONCOLOGY. 2023; 41(16)DOI:10.1200/JCO.22.00255. PMID:36730884. IF:42.100(Q1/1D).
01/01/2023
Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies
García-Calderón C.B., Sierro-Martínez B., García-Guerrero E., Sanoja-Flores L., Muñoz-García R., Ruiz-Maldonado V., Jimenez-Leon M.R., Delgado-Serrano J., Molinos-Quintana Á., Guijarro-Albaladejo B., Carrasco-Brocal I., Lucena J.-M., García-Lozano J.-R., Blázquez-Goñi C., Reguera-Ortega J.L., González-Escribano M.-F., Reinoso-Segura M., Briones J., Pérez-Simón J.A., Caballero-Velázquez T.. Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1152498. PMID:37122702. IF:5.700(Q1/3D).
01/01/2023
Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population
Olive-Gadea, M, de la Ossa, NP, Jovin, T, Abilleira, S, Jimenez, X, Cardona, P, Chamorro, A, Flores, A, Silva, Y, Purroy, F, Marti-Fabregas, J, Rodriguez-Campello, A, Zaragoza, J, Krupinski, J, Canovas, D, Choco, MG, Mas, N, Palomeras, E, Cocho, D, Aragones, JM, Repullo, C, Sanjurjo, E, Carrion, D, Catena, E, Costa, X, Almendros, MC, Barcelo, M, Monedero, J, Rybyeva, M, Diaz, G, Ribo, M. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population. International Journal of Stroke. 2023; 18(2)DOI:10.1177/17474930221093523. PMID:35373657. IF:6.300(Q1/1D).
01/01/2023
First pass effect in posterior circulation occlusions: Analysis from the CICAT registry
Terceno, M, Silva, Y, Bashir, S, Chamorro, A, de la Ossa, NP, Hernandez-Perez, M, Castano, C, Camps-Renom, P, Wenger, D, Cardona, P, Molina, C, Rodriguez-Campello, A, Canovas, D, Purroy, F, Salvat-Plana, M, Serena, J. First pass effect in posterior circulation occlusions: Analysis from the CICAT registry. International Journal of Stroke. 2023; 18(2)DOI:10.1177/17474930221089772. PMID:35272563. IF:6.300(Q1/1D).
01/01/2023
Presence of Ceramidase Activity in Electronegative LDL
Puig N., Rives J., Estruch M., Aguilera-Simon A., Rotllan N., Camacho M., Colomé N., Canals F., Sánchez-Quesada J.L., Benitez S.. Presence of Ceramidase Activity in Electronegative LDL. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023; 24(1)DOI:10.3390/ijms24010165. PMID:36613609. IF:4.900(Q1/3D).
01/01/2023
Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries
Amalia B., Fu M., Tigova O., Ballbè M., Paniello-Castillo B., Castellano Y., Vyzikidou V.K., O'Donnell R., Dobson R., Lugo A., Veronese C., Pérez-Ortuño R., Pascual J.A., Cortés N., Gil F., Olmedo P., Soriano J.B., Boffi R., Ruprecht A., Ancochea J., López M.J., Gallus S., Vardavas C., Semple S., Fernández E.. Exposure to secondhand aerosol from electronic cigarettes at homes: A real-life study in four European countries. The Science of the total environment. 2023; 854DOI:10.1016/j.scitotenv.2022.158668. PMID:36099951. IF:8.200(Q1/1D).
01/01/2023
Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial
Sarasate M., González N., Córdoba-Izquierdo A., Prats E., Gonzalez-Moro, JMR, Martí S., Lujan M., Calle M., Antón A., Povedano M., Farrero E.. Impact of Early Non-Invasive Ventilation in Amyotrophic Lateral Sclerosis: A multicenter Randomized Controlled Trial. Journal Of Neuromuscular Diseases. 2023; 10(4)DOI:10.3233/JND-221658. PMID:37212068. IF:3.200(Q2/3D).
01/01/2023
Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review
Corominas H., Young D., Cummings J.R.F., Bouhnik Y., Armuzzi A., Thaci D., Kim J.. Healthcare Professional (HCP) and Patient Usability Evaluation and Preferences of Two Auto-injector Devices for Self-Injection of Biosimilars, SB4 and SB5: A Literature Review. CLINICAL DRUG INVESTIGATION. 2023; 43(8)DOI:10.1007/s40261-023-01284-5. PMID:37615857. IF:(Q/D).
01/01/2023
A crowdsourcing database for the copy-number variation of the Spanish population
López-López D., Roldán G., Fernández-Rueda J.L., Bostelmann G., Carmona R., Aquino V., Perez-Florido J., Ortuño F., Pita G., Núñez-Torres R., González-Neira A., Alonso A., Salgado-Garrido J., Pasalodos-Sanchez S., Ayuso C., Minguez P., Avila-Fernandez A., Corton M., Artuch R., Borrego S., Antiñolo G., Carracedo A., Amigo J., Castaño L.A., Tejada I., Delmiro A., Espinos C., Grinberg D., Guillén E., Lapunzina P., Lopez-Escámez J.A., Gallego-Martinez A., Martí R., Rovira E., Millán J.M., Moreno M.A., Morin M., Moreno-Galdó A., Fernández-Cancio M., Morte B., Mulero V., García D., Nunes V., Palau F., Perez B., Jurado L.P., Perona R., Pujol A., Ramos F., Lopez E., Ribes A., Rosell J., Surrallés J., Peña-Chilet M., Dopazo J.. A crowdsourcing database for the copy-number variation of the Spanish population. Human Genomics. 2023; 17(1)DOI:10.1186/s40246-023-00466-8. PMID:36894999. IF:3.800(Q2/3D).
01/01/2023
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer with High Tumor Mutation Burden: A Nonrandomized Controlled Trial
Provencio M., Ortega A.L., Coves-Sarto J., Calvo V., Marsé-Fabregat R., Dómine M., Guirado M., Carcereny E., Fernández N., Álvarez R., Blanco R., León-Mateos L., Sánchez-Torres J.M., Sullivan I.G., Cobo M., Sánchez-Hernández A., Massuti B., Sierra-Rodero B., Mártinez-Toledo C., Serna-Blasco R., Romero A., Cruz-Bermúdez A.. Atezolizumab Plus Bevacizumab as First-line Treatment for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer with High Tumor Mutation Burden: A Nonrandomized Controlled Trial. JAMA Oncology. 2023; 9(3)DOI:10.1001/jamaoncol.2022.5959. PMID:36520426. IF:22.300(Q1/1D).
01/01/2023
Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes
Blanco R., Dómine M., González J.L., Loutfi S., Alfaro J., Saldaña J., Rubio J., Campos B., Hidalgo J., Barba A., Márquez D., Martin M., Olaverri A., Nadal E.. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. LUNG CANCER. 2023; 183DOI:10.1016/j.lungcan.2023.107318. PMID:37557022. IF:4.500(Q1/2D).
01/01/2023
Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma
Castillo J.A., Plaza V., Rodrigo G., Juliá B., Picado C., Fernández C., Mullol J.. Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma. Journal Of Allergy And Clinical Immunology: Global. 2023; 2(4)DOI:10.1016/j.jacig.2023.100134. PMID:37781668. IF:(Q/D).
01/01/2023
BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors
Bertran-Alamillo J., Giménez-Capitán A., Román R., Talbot S., Whiteley R., Floc’h N., Martínez-Pérez E., Martin M.J., Smith P.D., Sullivan I., Terp M.G., Saeh J., Marino-Buslje C., Fabbri G., Guo G., Xu M., Tornador C., Aguilar-Hernández A., Reguart N., Ditzel H.J., Martínez-Bueno A., Nabau-Moretó N., Gascó A., Rosell R., Pease J.E., Polanska U.M., Travers J., Urosevic J., Molina-Vila M.A.. BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors. Molecular Cancer. 2023; 22(1)DOI:10.1186/s12943-023-01815-w. PMID:37443114. IF:27.700(Q1/1D).
01/01/2023
Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders
Segal A., Parkes L., Aquino K., Kia S.M., Wolfers T., Franke B., Hoogman M., Beckmann C.F., Westlye L.T., Andreassen O.A., Zalesky A., Harrison B.J., Davey C.G., Soriano-Mas C., Cardoner N., Tiego J., Yücel M., Braganza L., Suo C., Berk M., Cotton S., Bellgrove M.A., Marquand A.F., Fornito A.. Regional, circuit and network heterogeneity of brain abnormalities in psychiatric disorders. NATURE NEUROSCIENCE. 2023; 26(9)DOI:10.1038/s41593-023-01404-6. PMID:37580620. IF:21.300(Q1/1D).
01/01/2023
Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease
Fortea, J, Garcia-Arcelay, E, Terrancle, A, Galvez, B, Diez-Carreras, V, Rebollo, P, Maurino, J, Garcia-Ribas, G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1)DOI:10.3233/JAD-221160. PMID:36970902. IF:3.400(Q2/4D).
01/01/2023
Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease
Ortiz, A, Ars, E, Bernis, C, Fraga, G, Furlano, M, Martinez, V, Martins, J, Perez-Gomez, MV, Rodriguez-Perez, JC, Sans, L, Torra, R. Reply to Comments on the SENefro Consensus Document on Autosomal Dominant Polycystic Kidney Disease. NEFROLOGIA. 2023; 43(1)DOI:10.1016/j.nefro.2022.07.002. PMID:37217372. IF:2.000(Q2/5D).
01/01/2023
The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.
Sampedro F. The success of assessing cortical microstructure through surface-based diffusion-weighted neuroimaging.. CLINICAL NEUROLOGY AND NEUROSURGERY. 2023; 234DOI:10.1016/j.clineuro.2023.107990. PMID:37806052. IF:1.800(Q2/5D).
01/01/2023
The polygenic basis of relapse after a first episode of schizophrenia
Segura À.-G., Prohens L., Gassó P., Rodríguez N., Garcia-Rizo C., Moreno-Izco L., Andreu-Bernabeu Á., Zorrilla I., Mane A., Rodriguez-Jimenez R., Roldán A., Sarró S., Ibáñez Á., Usall J., Sáiz P.A., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., Mezquida G., Arbelo N., De Matteis M., Galvañ J., Duque Guerra A., Arias i Queralt L., Perez-Bacigalupe M., Gonzalez-Ortega I., Toll A., Casanovas F., Sanchez-Pastor L., Valtueña M., Pomarol-Clotet E., García-León M.Á., Butjosa A., Rubio-Abadal E., Ribeiro M., López-Ilundain J.M., Saiz-Ruiz J., León-Quismondo L., Rivero O., Ruiz P., Echevarría R.S., García-Portilla M.P.. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:(Q/D).
01/01/2023
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/ Dependency) Classification Correlates with Disease Severity and Quality of Life
Santos-Garcia, D, Fonticoba, TD, Bartolome, CC, Painceiras, MJF, Iniguez-Alvarado, MC, Diaz, IG, Jesus, S, Buongiorno, MT, Planellas, L, Cosgaya, M, Caldentey, JG, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Rivera, MAA, Mayordomo, VG, Nogueira, V, Puente, V, Garcia-Sotos, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Padilla, FC, Castrillo, JCM, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Kulisevsky, J, Gonzalez, MM, Seijo, M, Martinez, JR, Valero, C, Kurtis, M, Ardura, JG, Redondo, RA, Ordas, C, Diaz, LML, McAfee, D, Calopa, M, Carrillo, F, Sevilla, FE, Freire-Alvarez, E, Esteban, JCG, Ramos, RG, Luquin, MRI, Martinez-Torres, I, Ignacio, AS, Martinez-Martin, P, Mir, P. Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/ Dependency) Classification Correlates with Disease Severity and Quality of Life. Journal of Parkinsons Disease. 2023; 13(3)DOI:10.3233/JPD-225073. PMID:36911948. IF:4.000(Q2/3D).
01/01/2023
Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study
González-Sánchez C., Salvador-Egea M.P., Glückmann-Maldonado E., Ríos A., Martín-Fernández J., Pérez-García J.I., García-Lorenzo F., Flores-Pastor B., Gómez-Ramírez J., Ortega-Serrano J., Ros-López S., Villar-del-Moral J., Morales-García D., Gutiérrez-Rodríguez M.T., Domènech-Calvet J., Nuño-Vázquez-Garza J.M., Franch-Arcas G.. Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study. LANGENBECKS ARCHIVES OF SURGERY. 2023; 408(1)DOI:10.1007/s00423-023-02945-x. PMID:37221304. IF:2.100(Q2/4D).
01/01/2023
Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations
Suárez-Calvet X., Fernández-Simón E., Natera D., Jou C., Pinol-Jurado P., Villalobos E., Ortez C., Monceau A., Schiava M., Codina A., Verdu-Díaz J., Clark J., Laidler Z., Mehra P., Gokul-Nath R., Alonso-Perez J., Marini-Bettolo C., Tasca G., Straub V., Guglieri M., Nascimento A., Diaz-Manera J.. Decoding the transcriptome of Duchenne muscular dystrophy to the single nuclei level reveals clinical-genetic correlations. Cell Death & Disease. 2023; 14(9)DOI:10.1038/s41419-023-06103-5. PMID:37673877. IF:8.100(Q1/2D).
01/01/2023
Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies
Collet R., Caballero-Ávila M., Querol L.. Clinical and pathophysiological implications of autoantibodies in autoimmune neuropathies. REVUE NEUROLOGIQUE. 2023; 179(8)DOI:10.1016/j.neurol.2023.02.064. PMID:36907709. IF:2.800(Q2/4D).
01/01/2023
Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease
Mackenbach M.J., Willemse E.A.J., Van Den Dorpel J.J.A., Van Der Beek N.A.M.E., Díaz-Manera J., Rizopoulos D., Teunissen C., Van Der Ploeg A.T., Van Den Hout J.M.P.. Neurofilament Light and Its Association With CNS Involvement in Patients With Classic Infantile Pompe Disease. NEUROLOGY. 2023; 101(6)DOI:10.1212/WNL.0000000000207482. PMID:37336766. IF:8.400(Q1/1D).
01/01/2023
Risk-of-bias assessment of the randomized clinical trials and systematic reviews on surgical treatments for breast cancer-related lymphedema: A mapping review
Al-Sakkaf A.M., Bonfill X., Ardiles-Ruesjas S., Bendersky-Kohan J., Sola I., Masia J.. Risk-of-bias assessment of the randomized clinical trials and systematic reviews on surgical treatments for breast cancer-related lymphedema: A mapping review. Journal of Plastic Reconstructive and Aesthetic Surgery. 2023; 84DOI:10.1016/j.bjps.2023.05.002. PMID:37329747. IF:2.000(Q2/4D).
01/01/2023
Digitalization and official food safety inspections at retail establishments
Grau-Noguer E., Suppi R., Rodríguez-Sanz M., Serratosa J., Bolao A., Lundén J., Hau P., Melo de Vasconcelos F., Åberg R., Blomgren C., Lambert M., Leppik K., Vågsholm I., Kautto A.H., Lueckl J., Abeln-Richter S., Kamphausen R., Bammens E., Georgiades F., Altenburgs J., Portaña S.. Digitalization and official food safety inspections at retail establishments. FOOD CONTROL. 2023; 154DOI:10.1016/j.foodcont.2023.109950. PMID:. IF:5.600(Q1/2D).
01/01/2023
Strategy for the promotion of equitable and healthy relationships in educational centers in Barcelona
Pérez G., Bartroli M., Pasarín M.I., Artazcoz L., Juárez O.. Strategy for the promotion of equitable and healthy relationships in educational centers in Barcelona. Gaceta Sanitaria. 2023; 37DOI:10.1016/j.gaceta.2022.102286. PMID:36645958. IF:1.500(Q3/7D).
01/01/2023
Availability and costs of medicines for the treatment of tuberculosis in Europe
Günther G., Guglielmetti L., Leu C., Lange C., van Leth F., Hasan Hafizi, Khachatryan N., Aroyan H., Kabasakalyan E., Knappik M., Skrahina A., Klimuk D., Nikolenka A., Muylle I., Milanov V., Velkovska D., Tarinska N., Bachiyska E., Jankovic M., Pieridou D., Adamide T., Nicolaou N., Vasakova M., Sukholytka M., Kopeckà E., Folkvardsen D.B., Svensson E., Danilovits M., Kummik T., Vasankari T., Fréchet-Jachym M., Nahmiash A., Togonidze T., Avaliani Z., Kinkladze I., Aspindzelashvili R., Bichashvili T., Losaberidze G., Merabishvili T., Kalsdorf B., Manika K., Tsiakitzis K., Bakos A., Ægisdóttir T.R., Michelsen G.S., Karlsdóttir K., McLaughlin A.-M., Fitzgibbon M., Chemtob D., Codecasa L.R., Ferrarese M., Torri S., Gjocaj M., Kuksa L., Davidaviciene E., Wirtz G., Perrin M., Asciak A.P., Chesov D., de Lange W., Akkerman O., Poposka B.I., Mack U., Jensenius M., Kvalvik L., Mengshoel A.T., Kruczak K., Duarte R., Ribeiro N., Ibraim E., Kaluzhenina A., Barkanova O., Pesut D., Solovic I., Svetina P., Souza-Galvão M.-L.D., Millet J.-P., Casas X., Vives M., Bruchfeld J., Dalemo P., Jonsson J., Aeschbacher K., Keller P., Özkara S., Tiberi S., Chen C., Terleeva Y., Dudnyk A.. Availability and costs of medicines for the treatment of tuberculosis in Europe. CLINICAL MICROBIOLOGY AND INFECTION. 2023; 29(1)DOI:10.1016/j.cmi.2022.07.026. PMID:35961488. IF:10.900(Q1/1D).
01/01/2023
Entering into 2.0 cystinuria management with a medical digital tool to monitor urine pH: A prospective, randomized study
Angerri O., Gracia S., Rousaud F., Kanashiro A., Emiliani E.. Entering into 2.0 cystinuria management with a medical digital tool to monitor urine pH: A prospective, randomized study. Actas Urologicas Espanolas. 2023; 47(9)DOI:10.1016/j.acuro.2023.02.004. PMID:. IF:(Q/D).
01/01/2023
Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map
Salazar J., Bracchiglione J., Acosta-Dighero R., Meza N., Meade A.-G., Quintana M.J., Requeijo C., Rodríguez-Grijalva G., Santero M., Selva A., Solà I., Bonfill X., Salas K., Antequera A., Auladell-Rispau A., Urrútia G., Meinardi P., Irassar J., Simancas D., Dorantes R., Merchán A., Cantero Y., Hernandez E., Sugrañes M.. Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map. SUPPORTIVE CARE IN CANCER. 2023; 31(2)DOI:10.1007/s00520-022-07564-8. PMID:36622453. IF:2.800(Q1/1D).
01/01/2023
Effect of COVID-19 prevention as part of an urban renewal programme
Fernández-Barrés S., Perez G., Piñero M., Reyes A., Pérez K., Artazcoz L., Borrell C.. Effect of COVID-19 prevention as part of an urban renewal programme. PUBLIC HEALTH. 2023; 223DOI:10.1016/j.puhe.2023.07.014. PMID:37666182. IF:3.900(Q1/2D).
01/01/2023
Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
Pujade-Lauraine E, Brown J, Barnicle A, Wessen J, Lao-Sirieix P, Criscione SW, du Bois A, Lorusso D, Romero I, Petru E, Yoshida H, Vergote I, Colombo N, Hietanen S, Provansal M, Schmalfeldt B, Pignata S, Martín Lorente C, Berton D, Runnebaum IB, Ray-Coquard I. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.. JCO Precision Oncology. 2023; 7DOI:10.1200/PO.22.00258. PMID:36716415. IF:5.300(Q1/2D).
01/01/2023
Basic concepts for understanding and improving clinical appropriateness
Bonfill Cosp X.. Basic concepts for understanding and improving clinical appropriateness. Educacion Medica. 2023; 24(3)DOI:10.1016/j.edumed.2023.100813. PMID:. IF:(Q/D).